These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3329538)

  • 21. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
    Luzar MA
    Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD.
    Glancey GR; Cameron JS; Ogg CS
    Nephrol Dial Transplant; 1992; 7(7):627-31. PubMed ID: 1323074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
    Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
    Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) by Y-connected double bag systems.
    Wüst J; Binswanger U; Bichsel G
    Life Support Syst; 1985; 3 Suppl 1():107-11. PubMed ID: 3870548
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intraperitoneal immunoglobulin infusion on neutrophil function in CAPD children with and without peritonitis.
    Akman S; Güven AG; Ince S; Yegin O
    Adv Perit Dial; 1998; 14():239-42. PubMed ID: 10649732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitis.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Cantaluppi A; Salit M; Lamperi S
    ASAIO Trans; 1989; 35(3):421-3. PubMed ID: 2597493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients.
    Vlaanderen K; Bos HJ; de Fijter CW; Oe LP; van der Meulen J; Verbrugh HA; Beelen RH
    Nephron; 1991; 57(1):29-35. PubMed ID: 2046812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
    Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of low dose immunoglobulin in the treatment of refractory CAPD peritonitis and longevity of technical survival on CAPD.
    Dursun B; Tuncer M; Felek R; Ersoy FF
    Int Urol Nephrol; 2005; 37(3):565-9. PubMed ID: 16307343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [UV irradiation of the peritoneal dialysis solution for the prevention of peritonitis].
    Tolon M; Ohgke H; Botzenhart K; Sack K
    Klin Wochenschr; 1983 Nov; 61(22):1137-9. PubMed ID: 6418948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
    Coban E; Ozdogan M; Tuncer M; Bozcuk H; Ersoy F
    J Nephrol; 2004; 17(3):427-30. PubMed ID: 15365965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disturbed host defense in peritoneal cavity during CAPD: characterization of responsible factors in dwell fluid.
    Vanholder R; Lameire N; Waterloos MA; Van Landschoot N; De Smet R; Vogeleere P; Lambert MC; Vijt D; Ringoir S
    Kidney Int; 1996 Aug; 50(2):643-52. PubMed ID: 8840297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
    Liu J; Huang X; Liu Y; Xu H; Gong R; Li C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1328-1333. PubMed ID: 28070047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.